Evidence map›Paper›PMID 36634075›Full record

ArticlePloS one2023

Antitumor effect of selenium-rich Brazil nuts and selenomethionine dietary supplementation on pre-existing 4T1 mammary tumor growth in mice.

Marina Apocalypse Nogueira Pereira, Ediu Carlos da Silva Junior, Istefani Luciene Dayse da Silva, Bárbara Andrade de Carvalho, Enio Ferreira, Eric Francelino Andrade, Luiz Roberto Guimarães Guilherme, Luciano José Pereira

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marina Apocalypse Nogueira PereiraDepartment of Veterinary Sciences, Universidade Federal de Lavras (UFLA), Lavras, Minas Gerais, Brazil.ORCID 0000-0003-2731-9532
Ediu Carlos da Silva JuniorDepartment of Soil Sciences, Universidade Federal de Lavras (UFLA), Lavras, Minas Gerais, Brazil.ORCID 0000-0001-8592-2204
Istefani Luciene Dayse da SilvaDepartment of Pathology, Universidade Federal Fluminense (UFF), Niterói, Rio de Janeiro, Brazil.
Bárbara Andrade de CarvalhoBiological Sciences Institute (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
Enio FerreiraBiological Sciences Institute (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
Eric Francelino AndradeDepartment of Health Sciences, Universidade Federal de Lavras (UFLA), Lavras, Minas Gerais, Brazil.
Luiz Roberto Guimarães GuilhermeDepartment of Soil Sciences, Universidade Federal de Lavras (UFLA), Lavras, Minas Gerais, Brazil.
Luciano José PereiraDepartment of Health Sciences, Universidade Federal de Lavras (UFLA), Lavras, Minas Gerais, Brazil.ORCID 0000-0002-0502-2554
Universidade Federal de Lavras · BRUniversidade Federal de Minas Gerais · BRUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selenium (Se) is an essential micronutrient known to play an important role in the antioxidant system that can potentially influence tumor growth. We aimed to investigate the effects of dietary Se supplementation after detection of 4T1 mammary tumor growth in BALB/c mice. Thirty female mice received subcutaneous inoculation of 4T1 cells. After five days, all animals presenting palpable tumors were randomly assigned to three groups: a control group (Se-control) receiving a diet with adequate Se (0.15 mg/kg) and two other groups that received Se-supplemented diets (1.4 mg/kg of total Se) with either Brazilian nuts (Se-Nuts) or selenomethionine (SeMet). Data were assessed by either One or Two-way ANOVA followed by Tukey's HSD or Bonferroni's post hoc tests, respectively. Both Se-supplemented diets reduced tumor volume from the thirteenth day of feeding compared with the Se-adequate (control) diet (p < 0.05). The SeMet group presented a higher Se blood concentration (p < 0.05) than the Se-control group, with the Se-Nuts group presenting intermediate values. Selenoprotein P gene expression in the liver was higher in the Se-Nuts group than in the Se-control group (p < 0.05), while the SeMet group presented intermediate expression. Dietary Se supplementation, starting after detection of 4T1 palpable lesions, reduced tumor volume in mice.

Indexed as

BertholletiaMammary Neoplasms, AnimalSeleniumAnimalsDietDietary SupplementsFemaleMiceSelenomethionineSeleniumSelenomethionine

Identifiers

PMID36634075
PMCPMC9836315
OpenAlexW4315709397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.